On the personal utility of Alzheimer’s disease-related biomarker testing in the research context

Last Updated: 29-08-2018

Personal utility of Alzheimer’s disease-related biomarker testing in the research context.pdf

Who are we and what are we doing? Read recent interviews with #epadistas on our website to find out more: ep-ad.org/2018/07/25/int… pic.twitter.com/03X8OaUbCG

6:21 am · 2018-10-19

EPAD

@IMI_EPAD

You are still on time to register for the #NRSConf18 celebrating the strength of Scotland’s #research environment. The @IMI_EPAD research participant panel will be presented via a poster presentation on October 30. bit.ly/2QVzUgB twitter.com/NHSResearchSco…

9:40 am · 2018-10-16

EPAD

@IMI_EPAD

We will be there with 5 poster presentations and 1 talk. Professor @craig_ritchie68 from @CenDemPrevent will present a summary of @IMI_EPAD’s First Formal Data Lock (EPAD V500.0) and predictors of amyloid status at #CTAD2018. twitter.com/CTADconference…

7:36 am · 2018-10-16

EPAD

@IMI_EPAD

The @IMI_EPAD quarterly newsletter will be sent on Friday 26th October. Not subscribed yet? ➡️➡️ep-ad.org/news-publicati… pic.twitter.com/tFaFwPPqQf

1:15 pm · 2018-10-12

EPAD

@IMI_EPAD

Our @IMI_EPAD WP6 members had a productive meeting in #Amsterdam last week with a lot of discussions and suggestions to update the communications strategy for 2019. The team is looking forward to implementing them now! bit.ly/2NA0dXy pic.twitter.com/Sr5LwGxBBF

11:36 am · 2018-10-12